Mark Sculpher : Citation Profile


Are you Mark Sculpher?

14

H index

17

i10 index

818

Citations

RESEARCH PRODUCTION:

29

Articles

18

Papers

2

Books

2

Chapters

RESEARCH ACTIVITY:

   23 years (1995 - 2018). See details.
   Cites by year: 35
   Journals where Mark Sculpher has often published
   Relations with other researchers
   Recent citing documents: 89.    Total self citations: 23 (2.73 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/psc810
   Updated: 2021-09-18    RAS profile: 2018-10-25    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Claxton, Karl (3)

Authors registered in RePEc who have co-authored more than one work in the last five years with Mark Sculpher.

Is cited by:

Brouwer, Werner (32)

Claxton, Karl (25)

Asaria, Miqdad (12)

Walker, Simon (11)

Culyer, Anthony (10)

van Exel, Job (10)

Devlin, Nancy (8)

Russell, Louise (6)

Revill, Paul (6)

Soares, Marta (5)

EPSTEIN, DAVID (5)

Cites to:

Claxton, Karl (61)

Brouwer, Werner (17)

Johannesson, Magnus (14)

Rice, Nigel (14)

Culyer, Anthony (14)

McCabe, Christopher (10)

Mullahy, John (10)

Walker, Simon (10)

Devlin, Nancy (7)

Martin, Stephen (7)

Parkin, David (6)

Main data


Where Mark Sculpher has published?


Journals with more than one article published# docs
Health Economics16
PharmacoEconomics8
The European Journal of Health Economics2

Working Papers Series with more than one paper published# docs
Working Papers / Centre for Health Economics, University of York13
Centre for Health Economics and Policy Analysis Working Paper Series / Centre for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Canada3

Recent works citing Mark Sculpher (2021 and 2020)


YearTitle of citing document
2020A quantitative framework to inform extrapolation decisions in children. (2020). Jaki, Thomas ; Sills, Graeme J ; Marson, Anthony G ; Wadsworth, Ian ; Hampson, Lisa V ; Appleton, Richard. In: Journal of the Royal Statistical Society Series A. RePEc:bla:jorssa:v:183:y:2020:i:2:p:515-534.

Full description at Econpapers || Download paper

2020A Bayesian parametric approach to handle missing longitudinal outcome data in trial‐based health economic evaluations. (2020). Daniels, Michael J ; Gabrio, Andrea ; Baio, Gianluca. In: Journal of the Royal Statistical Society Series A. RePEc:bla:jorssa:v:183:y:2020:i:2:p:607-629.

Full description at Econpapers || Download paper

2021Paying for health gains. (2021). Chalkley, Martin ; Gravelle, Hugh ; Gutacker, Nils ; Gaughan, James ; Siciliani, Luigi. In: Working Papers. RePEc:chy:respap:183cherp.

Full description at Econpapers || Download paper

2020Long Way to Universal Health Coverage (UHC): Are Policy Dialogue Processes Appropriate to Negotiate Trade-Offs in Africa? The Cases of Benin and Senegal. (2020). Emmanuelsambini, Nakou ; Sall, Farba Lamine ; Ndiaye, Youssoupha ; Deville, Cline ; Fecher, Fabienne ; Paul, Elisabeth ; Porignon, Denis ; Meloni, Remo. In: CIRIEC Working Papers. RePEc:crc:wpaper:2005.

Full description at Econpapers || Download paper

2020The Value of Health - Empirical Issues when Estimating the Monetary Value of a QALY Based on Well-Being. (2020). Brouwer, Werner ; van Exel, Job ; Stockel, Jannis ; Himmler, Sebastian. In: SOEPpapers on Multidisciplinary Panel Data Research. RePEc:diw:diwsop:diw_sp1101.

Full description at Econpapers || Download paper

2021Robustness of cost-effectiveness analyses of cluster randomized trials assuming bivariate normality against skewed cost data. (2021). , Gerard ; Manju, Md Abu. In: Computational Statistics & Data Analysis. RePEc:eee:csdana:v:157:y:2021:i:c:s0167947320302346.

Full description at Econpapers || Download paper

2020Modelling the impact of physical activity on public health: A review and critique. (2020). Meads, David ; Candio, Paolo ; Bojke, Laura ; Hill, Andrew J. In: Health Policy. RePEc:eee:hepoli:v:124:y:2020:i:10:p:1155-1164.

Full description at Econpapers || Download paper

2020Distributional equity as a consideration in economic and modelling evaluations of health taxes: A systematic review. (2020). Chalkidou, Kalipso ; Baker, Peter ; Crosby, Liam ; Jain, Vageesh. In: Health Policy. RePEc:eee:hepoli:v:124:y:2020:i:9:p:919-931.

Full description at Econpapers || Download paper

2021Cancer care at home or in local health centres versus in hospital: Public policy goals and patients’ preferences in the Rhône-Alps region in France. (2021). Margier, Jennifer ; Moumjid, Nora ; Gafni, Amiram. In: Health Policy. RePEc:eee:hepoli:v:125:y:2021:i:2:p:213-220.

Full description at Econpapers || Download paper

2021Taking a local government perspective for economic evaluation of a population-level programme to promote exercise. (2021). Bojke, Laura ; Hill, Andrew J ; Meads, David ; Candio, Paolo. In: Health Policy. RePEc:eee:hepoli:v:125:y:2021:i:5:p:651-657.

Full description at Econpapers || Download paper

2020Opportunity cost neglect in public policy. (2020). Persson, Emil ; Tinghog, Gustav. In: Journal of Economic Behavior & Organization. RePEc:eee:jeborg:v:170:y:2020:i:c:p:301-312.

Full description at Econpapers || Download paper

2020Advancing the evidence base for public policies impacting on dietary behaviour, physical activity and sedentary behaviour in Europe: The Policy Evaluation Network promoting a multidisciplinary approac. (2020). Mazzocchi, Mario ; Van Lenthe, Frank ; Harrington, Janas M ; Stock, Christian C ; Flechtner-Mors, Marion ; Steinacker, Jurgen M ; Brenner, Hermann ; Roos, Gun ; Hebestreit, Antje ; Steenhuis, Ingrid ; Woods, Catherine ; Poelman, Maartje ; Lakerveld, Jeroen ; Murrin, Celine ; Ahrens, Wolfgang ; Luszczynska, Aleksandra ; Zukowska, Joanna ; Laxy, Michael ; Zeeb, Hajo. In: Food Policy. RePEc:eee:jfpoli:v:96:y:2020:i:c:s0306919220300750.

Full description at Ec

2020Optimal hospital payment rules under rationing by waiting. (2020). Gravelle, Hugh ; Schroyen, Fred. In: Journal of Health Economics. RePEc:eee:jhecon:v:70:y:2020:i:c:s0167629619302681.

Full description at Econpapers || Download paper

2020Advances in the methodological approach to friction period estimation: A European perspective. (2020). Sharp, Linda ; Soerjomataram, Isabelle ; Pearce, Alison ; Ortega, Marta Ortega ; Hanly, Paul. In: Social Science & Medicine. RePEc:eee:socmed:v:264:y:2020:i:c:s0277953620305086.

Full description at Econpapers || Download paper

2021Cost-effectiveness analysis of housing first intervention with an independent housing and team support for homeless people with severe mental illness: A Markov model informed by a randomized controlle. (2021). Auquier, Pascal ; Tinland, Aurelie ; Girard, Vincent ; Boucekine, Mohamed ; Loubiere, Sandrine ; Lemoine, Coralie. In: Social Science & Medicine. RePEc:eee:socmed:v:272:y:2021:i:c:s0277953621000241.

Full description at Econpapers || Download paper

2021Providing universal access to modern contraceptive methods: An extended cost-effectiveness analysis of meeting the demand for modern contraception in Ethiopia. (2021). Norheim, O F ; Tolla, M T ; Enden, M R. In: Social Science & Medicine. RePEc:eee:socmed:v:281:y:2021:i:c:s0277953621004081.

Full description at Econpapers || Download paper

2021Modelling the economic impact of reducing loneliness in community dwelling older people in england. (2021). A-La Park, ; McDaid, David. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:108594.

Full description at Econpapers || Download paper

2021Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution. (2021). Duval, Laetitia ; Kamate, Beh ; Diawara, Fatou ; Steinhardt, Laura ; Conteh, Lesong ; Cairns, Matt ; Dicko, Alassane ; Walker, Patrick ; Eckert, Erin ; Mihigo, Jules ; Sadou, Aboubacar ; Sagara, Issaka ; Sicuri, Elisa. In: Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers). RePEc:hal:cesptp:hal-03184961.

Full description at Econpapers || Download paper

2021Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial). (2021). Bousmah, Marwân-al-Qays ; Maradan, Gwenaelle ; Mpoudi-Etame, Mireille ; Wandji, Martial Lantche ; Tovar-Sanchez, Tamara ; Nishimwe, Marie ; Boyer, Sylvie ; Marwan-Al-Qays Bousmah, ; Delaporte, Eric ; Kouanfack, Charles ; Montoyo, Alice ; Varloteaux, Marie ; Bassega, Pierrette Omgba. In: Post-Print. RePEc:hal:journl:hal-03174666.

Full description at Econpapers || Download paper

2021Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution. (2021). Duval, Laetitia ; Kamate, Beh ; Diawara, Fatou ; Steinhardt, Laura ; Conteh, Lesong ; Cairns, Matt ; Dicko, Alassane ; Walker, Patrick ; Eckert, Erin ; Mihigo, Jules ; Sadou, Aboubacar ; Sagara, Issaka ; Sicuri, Elisa. In: Post-Print. RePEc:hal:journl:hal-03184961.

Full description at Econpapers || Download paper

2020Early Childhood Education and Life-cycle Health. (2020). Garcia, Jorge Luis ; Heckman, James J. In: Working Papers. RePEc:hka:wpaper:2020-011.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2020Early Childhood Education and Life-cycle Health. (2020). Heckman, James J ; Garcia, Jorge Luis. In: IZA Discussion Papers. RePEc:iza:izadps:dp13064.

Full description at Econpapers || Download paper

2020Early Childhood Education and Life-cycle Health. (2020). Garcia, Jorge Luis ; Heckman, James J. In: NBER Working Papers. RePEc:nbr:nberwo:26880.

Full description at Econpapers || Download paper

2020Leprosy post-exposure prophylaxis in the Indian health system: A cost-effectiveness analysis. (2020). Richardus, Jan Hendrik ; Arif, Mohammad ; Blok, David J ; Tiwari, Anuj. In: PLOS Neglected Tropical Diseases. RePEc:plo:pntd00:0008521.

Full description at Econpapers || Download paper

2020A non-stationary Markov model for economic evaluation of grass pollen allergoid immunotherapy. (2020). di Bona, Danilo ; Pasculli, Giuseppe ; Bilancia, Massimo . In: PLOS ONE. RePEc:plo:pone00:0232753.

Full description at Econpapers || Download paper

2020Cost-effectiveness analysis of an outreach model of Hepatitis C Virus (HCV) assessment to facilitate HCV treatment in primary care. (2020). Obeirne, James ; Mitchell, Jonathan ; Brain, David. In: PLOS ONE. RePEc:plo:pone00:0234577.

Full description at Econpapers || Download paper

2020Moving towards malaria elimination in southern Mozambique: Cost and cost-effectiveness of mass drug administration combined with intensified malaria control. (2020). Alonso, Pedro ; Marti-Soler, Helena ; Aide, Pedro ; Mamuquele, Miler ; MacEte, Eusebio ; Paaijmans, Krijn ; Rabinovich, Regina ; Candrinho, Baltazar ; Galatas, Beatriz ; Bassat, Quique ; Cirera, Laia ; Montaa, Julia ; Nhantumbo, Hoticha ; Luis, Fabio ; Sicuri, Elisa ; Munguambe, Humberto ; Saute, Francisco ; Guinovart, Caterina. In: PLOS ONE. RePEc:plo:pone00:0235631.

Full description at Econpapers || Download 2020

Spillover Effects of Retirement: does health vulnerability matter?. (2020). Tang, Kam Ki ; Kwak, Do Won ; Yazbeck, Myra ; Byrne, Dominic . In: Discussion Papers Series. RePEc:qld:uq2004:620.

Full description at Econpapers || Download paper

2021Spillover Effects of Retirement: does health vulnerability matter?. (2021). Tang, Kam Ki ; Yazbeck, Myra ; Ki, Kam ; Kwak, Do Won ; Byrne, Dominic . In: Discussion Papers Series. RePEc:qld:uq2004:643.

Full description at Econpapers || Download paper

2020.

Full description at Econpapers || Download paper

2020.

Full description at Econpapers || Download paper

2020.

Full description at Econpapers || Download paper

2020.

Full description at Econpapers || Download paper

2020.

Full description at Econpapers || Download paper

2020.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2021.

Full description at Econpapers || Download paper

2020Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriatic Arthritis in Germany. (2020). Ostwald, Dennis A ; Gandjour, Afschin. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:18:y:2020:i:1:d:10.1007_s40258-019-00523-1.

Full description at Econpapers || Download paper

2020Cost-Effectiveness of a School-Based Social and Emotional Learning Intervention: Evidence from a Cluster-Randomised Controlled Trial of the Promoting Alternative Thinking Strategies Curriculum. (2020). Turner, Alex J ; Humphrey, Neil ; Hennessey, Alexandra ; Harrison, Mark ; Sutton, Matt. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:18:y:2020:i:2:d:10.1007_s40258-019-00498-z.

Full description at Econpapers || Download paper

2020Cost-Effectiveness of Dementia Care Mapping in Care-Home Settings: Evaluation of a Randomised Controlled Trial. (2020). Meads, David M ; Surr, Claire A ; Ballard, Clive ; Walwyn, Rebecca ; McDermid, Joanne ; Robinson, Louise ; Creese, Byron ; Kelley, Rachael ; Griffiths, Alys ; Martin, Adam. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:18:y:2020:i:2:d:10.1007_s40258-019-00531-1.

Full description at Econpapers || Download paper

2020Systematic Review of Economic Evaluations of Services Provided by Community Pharmacists. (2020). Husereau, Don ; Sanyal, Chiranjeev. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:18:y:2020:i:3:d:10.1007_s40258-019-00535-x.

Full description at Econpapers || Download paper

2020Value-Based Pricing Alternatives for Personalised Drugs: Implications of Asymmetric Information and Competition. (2020). Pertile, Paolo ; LEVAGGI, ROSELLA. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:18:y:2020:i:3:d:10.1007_s40258-019-00541-z.

Full description at Econpapers || Download paper

2020Constrained Optimization for the Selection of Influenza Vaccines to Maximize the Population Benefit: A Demonstration Project. (2020). Carrico, Justin ; Hicks, Katherine ; Talbird, Sandra ; van Bellinghen, Laure-Anne ; van Vlaenderen, Ilse ; Standaert, Baudouin ; Buck, Philip O. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:18:y:2020:i:4:d:10.1007_s40258-019-00534-y.

Full description at Econpapers || Download paper

2020Cost–Utility of Internet-Based Cognitive Behavioral Therapy in Unipolar Depression: A Markov Model Simulation. (2020). Frey, Simon ; Stargardt, Tom ; Baumann, Mathias. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:18:y:2020:i:4:d:10.1007_s40258-019-00551-x.

Full description at Econpapers || Download paper

2021Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator. (2021). Hindricks, Gerhard ; Dagres, Nikolaos ; Elsner, Christian ; Eisemann, Nora ; Frielitz, Fabian-Simon ; Hadwiger, Moritz ; Katalinic, Alexander. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:1:d:10.1007_s40258-020-00571-y.

Full description at Econpapers || Download paper

2021Economic Modelling of Screen-and-Treat Strategies for Brazilian Women at Risk of Hereditary Breast and Ovarian Cancer. (2021). Muller, Dirk ; Stock, Stephanie ; Estevez, Maria Pilar ; Correa-Galendi, Julia Simoes. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:1:d:10.1007_s40258-020-00599-0.

Full description at Econpapers || Download paper

2021Systematic Review and Critique of Methods for Economic Evaluation of Digital Mental Health Interventions. (2021). Melton, Hollie ; Churchill, Rachel ; Goncalves, Pedro Saramago ; Marshall, David ; Bojke, Laura ; Jankovic, Dina ; Gega, Lina ; Brabyn, Sally. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:1:d:10.1007_s40258-020-00607-3.

Full description at Econpapers || Download paper

2021Is the Choice of Cost-Effectiveness Threshold in Cost-Utility Analysis Endogenous to the Resulting Value of Technology? A Systematic Review. (2021). Phelps, Charles E ; Chen, Hui-Han ; Padula, William V. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:2:d:10.1007_s40258-020-00606-4.

Full description at Econpapers || Download paper

2021Management of Chest Indrawing Pneumonia in Children Under Five Years at the Outpatient Health Facilities in Nigeria: An Economic Evaluation. (2021). Okafor, Charles E. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:3:d:10.1007_s40258-020-00627-z.

Full description at Econpapers || Download paper

2021Copula Models for Addressing Sample Selection in the Evaluation of Public Health Programmes: An Application to the Leeds Let’s Get Active Study. (2021). Pulkki-Brannstrom, Anni-Maria ; Gomes, Manuel ; Poupakis, Stavros ; Bojke, Chris ; Hill, Andrew J ; Candio, Paolo. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:3:d:10.1007_s40258-020-00629-x.

Full description at Econpapers || Download paper

2021Cost-Effectiveness and Value of Information of Cabozantinib Treatment for Patients with Advanced Renal Cell Carcinoma After Failure of Prior Therapy in South Korea. (2021). Suh, Hae Sun ; Kim, Hyung Tae ; Han, Sola. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:4:d:10.1007_s40258-021-00640-w.

Full description at Econpapers || Download paper

2020Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy. (2020). Rodriguez-Sanchez, B ; Sinclair, A J ; Pea-Longobardo, L M. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:3:d:10.1007_s10198-019-01134-2.

Full description at Econpapers || Download paper

2020Early cost-utility analysis of tissue-engineered heart valves compared to bioprostheses in the aortic position in elderly patients. (2020). Huygens, Simone A ; Grunkemeier, Gary L ; Chiu, Shih Ting ; Kluin, Jolanda ; Ramos, Isaac Corro. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:4:d:10.1007_s10198-020-01159-y.

Full description at Econpapers || Download paper

2020Are quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems. (2020). Newhouse, Joseph ; Chen, Chih-Hung ; Quan, Jianchao ; Eggleston, Karen ; Struijs, Jeroen N ; Rodriguez-Sanchez, Beatriz ; Lu, Jui-Fen Rachel ; Leung, Gabriel M ; Kei, Janet Tin ; Iizuka, Toshiaki ; Feenstra, Talitha. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:21:y:2020:i:5:d:10.1007_s10198-020-01164-1.

Full description at Econpapers || Download 2021

Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses. (2021). Ramos-Goi, Juan M ; Estevez-Carrillo, Anabel ; Silvan, Carlos Vila ; Ortin-Sulbaran, Daniela ; Oppe, Mark. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:22:y:2021:i:5:d:10.1007_s10198-021-01285-1.

Full description at Econpapers || Download paper

2021Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands. (2021). Pol, Simon ; Postma, Maarten J ; Boersma, Cornelis ; Schans, Simon ; Hagendijk, Marije E. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:22:y:2021:i:6:d:10.1007_s10198-021-01303-2.

Full description at Econpapers || Download paper

2021Time-to-event analysis in economic evaluations: a comparison of modelling methods to assess the cost-effectiveness of transplanting a marginal quality kidney. (2021). Senanayake, Sameera ; Healy, Helen ; Baboolal, Keshwar ; Graves, Nicholas ; Kularatna, Sanjeewa ; Barnett, Adrian. In: Health Economics Review. RePEc:spr:hecrev:v:11:y:2021:i:1:d:10.1186_s13561-021-00312-4.

Full description at Econpapers || Download paper

2020Surrogate Endpoints in Health Technology Assessment: An International Review of Methodological Guidelines. (2020). Shatrov, Kosta ; Rabbe, Stefan ; Mollenkamp, Meilin ; Groot, Saskia ; Federici, Carlo ; Dams, Florian ; Ciani, Oriana ; Grigore, Bogdan ; Taylor, Rod S ; Zemplenyi, Antal. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:10:d:10.1007_s40273-020-00935-1.

Full description at Econpapers || Download paper

2020Estimating Transition Probabilities from Published Evidence: A Tutorial for Decision Modelers. (2020). Russell, Louise B ; Gidwani, Risha. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:11:d:10.1007_s40273-020-00937-z.

Full description at Econpapers || Download paper

2020Informing a Cost-Effectiveness Threshold for Health Technology Assessment in China: A Marginal Productivity Approach. (2020). Lomas, James ; Gu, Yuanyuan ; Wang, Haiyin ; Ochalek, Jessica ; Jin, Chunlin ; Cutler, Henry. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:12:d:10.1007_s40273-020-00954-y.

Full description at Econpapers || Download paper

2020Recalibrating Health Technology Assessment Methods for Cell and Gene Therapies. (2020). Hackshaw, Allan ; Naci, Huseyin ; Angelis, Aris. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:12:d:10.1007_s40273-020-00956-w.

Full description at Econpapers || Download paper

2020Cost Effectiveness of Teplizumab for Prevention of Type 1 Diabetes Among Different Target Patient Groups. (2020). Nguyen, Hai V ; Mital, Shweta. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:12:d:10.1007_s40273-020-00962-y.

Full description at Econpapers || Download paper

2020Influence of Modeling Choices on Value of Information Analysis: An Empirical Analysis from a Real-World Experiment. (2020). Carlson, Josh J ; Ramsey, Scott D ; Veenstra, David L ; Basu, Anirban ; Bennette, Caroline S ; Guzauskas, Gregory F ; Kim, David D. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:2:d:10.1007_s40273-019-00848-8.

Full description at Econpapers || Download paper

2020Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models. (2020). Joore, Manuela A ; Grutters, Janneke ; Knies, Saskia ; Wijnen, Ben ; Pouwels, Xavier ; Grimm, Sabine E. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:2:d:10.1007_s40273-019-00855-9.

Full description at Econpapers || Download paper

2020One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit. (2020). Hall, Peter ; Sutton, Andrew ; Awotwe, Isaac ; Paulden, Mike ; McCabe, Christopher . In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:2:d:10.1007_s40273-019-00869-3.

Full description at Econpapers || Download paper

2020Potential Bias Associated with Modeling the Effectiveness of Healthcare Interventions in Reducing Mortality Using an Overall Hazard Ratio. (2020). Kuntz, Karen M ; Alarid-Escudero, Fernando. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:3:d:10.1007_s40273-019-00859-5.

Full description at Econpapers || Download paper

2020After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator?. (2020). Palmer, Stephen ; Sculpher, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:3:d:10.1007_s40273-019-00882-6.

Full description at Econpapers || Download paper

2020Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with Recommendations. (2020). Richardson, Gerry ; Lomas, James ; Franklin, Matthew. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00907-5.

Full description at Econpapers || Download paper

2020Health Economic Models for Metastatic Colorectal Cancer: A Methodological Review. (2020). Gibbs, Peter ; Koopman, Miriam ; Wong, Hui-Li ; Koffijberg, Hendrik ; Vu, Martin ; Degeling, Koen ; Ijzerman, Maarten . In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00908-4.

Full description at Econpapers || Download paper

2020Inclisiran as Adjunct Lipid-Lowering Therapy for Patients with Cardiovascular Disease: A Cost-Effectiveness Analysis. (2020). Kam, Ning ; Ademi, Zanfina ; Liew, Danny ; Zomer, Ella ; Perera, Kanila. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:9:d:10.1007_s40273-020-00948-w.

Full description at Econpapers || Download paper

2021Quantitative Evidence Synthesis Methods for the Assessment of the Effectiveness of Treatment Sequences for Clinical and Economic Decision Making: A Review and Taxonomy of Simplifying Assumptions. (2021). Wilkinson, Clare ; Sutton, Alex J ; Hughes, Dyfrig ; Lewis, Ruth A. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:1:d:10.1007_s40273-020-00980-w.

Full description at Econpapers || Download paper

2021Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit Frontier. (2021). Paulden, Mike ; Hall, Peter ; Sutton, Andrew ; Tramonti, Giovanni ; McCabe, Christopher. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:1:d:10.1007_s40273-020-00983-7.

Full description at Econpapers || Download paper

2021Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve. (2021). Sendi, Pedram. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00969-5.

Full description at Econpapers || Download paper

2021Modifying NICE’s Approach to Equity Weighting. (2021). McCabe, Christopher ; Paulden, Mike. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00988-2.

Full description at Econpapers || Download paper

2021NICE’s Discounting Review: Clear Thinking on Rational Revision Meets Obstacle of Industrial Interests. (2021). Paulden, Mike ; Omahony, James F ; McCabe, Chris . In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:2:d:10.1007_s40273-020-00990-8.

Full description at Econpapers || Download paper

2021Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial). (2021). Bousmah, Marwân-al-Qays ; Varloteaux, Marie ; Bassega, Pierrette Omgba ; Maradan, Gwenaelle ; Mpoudi-Etame, Mireille ; Wandji, Martial Lantche ; Tovar-Sanchez, Tamara ; Nishimwe, Marie Liberee ; Boyer, Sylvie ; Marwan-Al-Qays Bousmah, ; Delaporte, Eric ; Kouanfack, Charles ; Montoyo, Alice. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:3:d:10.1007_s40273-020-00987-3.

Full description at Econpapers || Download 2021

The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United States. (2021). Kumar, Princy N ; La, Elizabeth M ; Davis, Ashley E ; Talbird, Sandra E ; Brogan, Anita J. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:4:d:10.1007_s40273-020-00992-6.

Full description at Econpapers || Download paper

2021Macrovascular Risk Equations Based on the CANVAS Program. (2021). Neslusan, Cheryl ; Nilsson, Andreas ; Slee, April ; Asseburg, Christian ; Willis, Michael. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:4:d:10.1007_s40273-021-01001-0.

Full description at Econpapers || Download paper

2020Early Economic Evaluation to Identify the Necessary Test Characteristics of a New Typhoid Test to be Cost Effective in Ghana. (2020). Barton, Pelham ; Davenport, Clare ; Sutton, Andrew J ; Frempong, Samuel N. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:1:d:10.1007_s41669-019-0159-7.

Full description at Econpapers || Download paper

2020A Systematic Review of Model-Based Economic Evaluations of Treatments for Venous Leg Ulcers. (2020). Layer, Ashley ; Levell, N J ; McManus, Emma. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:2:d:10.1007_s41669-019-0148-x.

Full description at Econpapers || Download paper

2020Managing Uncertainties Due to Limited Evidence in Economic Evaluations of Novel Anti-Tuberculosis Regimens: A Systematic Review. (2020). Armina, T I ; Hovels, Anke M ; Klungel, Olaf ; Frederix, Gerardus W ; Saragih, Sarah Maria. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:2:d:10.1007_s41669-019-0162-z.

Full description at Econpapers || Download paper

2020Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK. (2020). Malmberg, Chiara ; Schweikert, Bernd ; Hartz, Susanne ; Sapin, Christophe ; Kiri, Sandeep ; Nott, Debby ; Kumar, Gayathri ; kerborg, orjan . In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:4:d:10.1007_s41669-020-00202-1.

Full description at Econpapers || Download 2020

Is Protocolised Weaning that Includes Early Extubation Onto Non-Invasive Ventilation More Cost Effective Than Protocolised Weaning Without Non-Invasive Ventilation? Findings from the Breathe Study. (2020). Maredza, Mandy ; Khan, Iftekhar ; Petrou, Stavros ; Perkins, Gavin D ; Gates, Simon ; Couper, Keith ; Lamb, Sarah E ; Lall, Ranjit ; Mistry, Dipesh ; Dritsaki, Melina. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:4:y:2020:i:4:d:10.1007_s41669-020-00210-1.

Full description at Econpapers || Download 2021

Minimally Invasive Sacroiliac Joint Fusion with Triangular Titanium Implants: Cost-Utility Analysis from NHS Perspective. (2021). Newton, Matthew P ; Blissett, Rob S ; Reckling, Carlton W ; Cher, Daniel J ; Stott, Philip M. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:5:y:2021:i:2:d:10.1007_s41669-020-00236-5.

Full description at Econpapers || Download paper

2021Cost?effectiveness analysis of public health interventions with impacts on health and criminal justice: An applied cross?sectoral analysis of an alcohol misuse intervention. (2021). Richardson, Gerry ; Kanaan, Mona ; Coulton, Simon ; Deluca, Paolo ; Drummond, Colin ; Parrott, Steve ; Griffin, Susan ; Walker, Simon ; Ramponi, Francesco. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:5:p:972-988.

Full description at Econpapers || Download paper

2021Estimating optimal willingness to pay thresholds for cost?effectiveness analysis: A generalized method. (2021). Cinatl, Chris ; Phelps, Charles E. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:7:p:1697-1702.

Full description at Econpapers || Download paper

2021The value of health—Empirical issues when estimating the monetary value of a quality?adjusted life year based on well?being data. (2021). , Werner ; van Exel, Job ; Stockel, Jannis ; Himmler, Sebastian. In: Health Economics. RePEc:wly:hlthec:v:30:y:2021:i:8:p:1849-1870.

Full description at Econpapers || Download paper

2020Impact of a Global Pandemic on Health Technology Assessment. (2020). Adler, Amanda ; Lorgelly, Paula K. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:18:y:2020:i:3:d:10.1007_s40258-020-00590-9.

Full description at Econpapers || Download paper

Works by Mark Sculpher:


YearTitleTypeCited
2015Country-level cost-effectiveness thresholds: initial estimates and the need for further research In: Working Papers.
[Full Text][Citation analysis]
paper47
2016Supporting the development of an essential health package: principles and initial assessment for Malawi In: Working Papers.
[Full Text][Citation analysis]
paper2
2017Scoping review on social care economic evaluation methods In: Working Papers.
[Full Text][Citation analysis]
paper0
1999A critical structured review of economic evaluations of interventions for the prevention and treatment of osteoporosis In: Working Papers.
[Full Text][Citation analysis]
paper0
2000Improving the efficiency and relevance of health technology assessent: the role of iterative decision analytic modelling In: Working Papers.
[Full Text][Citation analysis]
paper7
2007Mark versus Luke? Appropriate Methods for the Evaluation of Public Health Interventions In: Working Papers.
[Full Text][Citation analysis]
paper6
2010Appropriate Perspectives for Health Care Decisions In: Working Papers.
[Full Text][Citation analysis]
paper41
2005The value of implementation and the value of information: combined and uneven development In: Working Papers.
[Full Text][Citation analysis]
paper3
2011Value-based pricing for pharmaceuticals: Its role, specification and prospects in a newly devolved NHS In: Working Papers.
[Full Text][Citation analysis]
paper5
2012Coverage with evidence development, only in research, risk sharing or patient access scheme? A framework for coverage decisions In: Working Papers.
[Full Text][Citation analysis]
paper21
2013Methods for the estimation of the NICE cost effectiveness threshold In: Working Papers.
[Full Text][Citation analysis]
paper49
2014Using cost-effectiveness thresholds to determine value for money in low- and middle-income country healthcare systems: Are current international norms fit for purpose? In: Working Papers.
[Full Text][Citation analysis]
paper7
2006Defining and characterising structural uncertainty in decision analytic models In: Working Papers.
[Full Text][Citation analysis]
paper6
2009Methods for assessing the cost-effectiveness of public health interventions: Key challenges and recommendations In: Health Policy.
[Full Text][Citation analysis]
article22
2002Shared treatment decision making in a collectively funded health care system: possible conflicts and some potential solutions In: Social Science & Medicine.
[Full Text][Citation analysis]
article3
2012Decision-making with Uncertainty: The Value of Information In: Chapters.
[Full Text][Citation analysis]
chapter0
2006Decision-making with Uncertainty: The Value of Information.(2006) In: Chapters.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
chapter
1999Recognizing Preference Diversity: The Use of Preference Sub-Groups in Cost-Effectiveness Analysis In: Centre for Health Economics and Policy Analysis Working Paper Series.
[Full Text][Citation analysis]
paper0
1999Income Effects of Reduced Health and Health Effects of Reduced Income: Implications for Health State Valuation In: Centre for Health Economics and Policy Analysis Working Paper Series.
[Full Text][Citation analysis]
paper0
1999Building Uncertainty into Cost-Effectiveness Rankings: Portfolio Risk-Return Trade-Offs and Implications for Decision Rules In: Centre for Health Economics and Policy Analysis Working Paper Series.
[Full Text][Citation analysis]
paper0
2000Productivity Costs: Principles and Practice in Economic Evaluation In: Monographs.
[Full Text][Citation analysis]
book9
2006Decision Modelling for Health Economic Evaluation In: OUP Catalogue.
[Citation analysis]
book257
2014What is the Quality of Economic Evaluations of Non-Drug Therapies? A Systematic Review and Critical Appraisal of Economic Evaluations of Radiotherapy for Cancer In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article0
2010An economic model for the prevention of MRSA infections after surgery: non-glycopeptide or glycopeptide antibiotic prophylaxis? In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0
2005Estimating utility data from clinical indicators for patients with stable angina In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article5
2000Costs Incurred by Patients Undergoing Advanced Colorectal Cancer Therapy In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2006Assessing Generalisability in Model-Based Economic Evaluation Studies In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2007A Comparison of the Cost Effectiveness of Pharmacotherapy or Surgery (Laparoscopic Fundoplication) in the Treatment of GORD In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2007Recombinant Erythropoietin for Chemotherapy-Related Anaemia In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2012Real Economics Needs to Reflect Real Decisions In: PharmacoEconomics.
[Full Text][Citation analysis]
article2
2012Golimumab for the Treatment of Psoriatic Arthritis In: PharmacoEconomics.
[Full Text][Citation analysis]
article25
2013Acknowledging Patient Heterogeneity in Economic Evaluation In: PharmacoEconomics.
[Full Text][Citation analysis]
article1
2016Should the Lambda (?) Remain Silent? In: PharmacoEconomics.
[Full Text][Citation analysis]
article0
2001Recognizing diversity in public preferences: The use of preference sub‐groups in cost‐effectiveness analysis In: Health Economics.
[Full Text][Citation analysis]
article14
2001Representing uncertainty: the role of cost‐effectiveness acceptability curves In: Health Economics.
[Full Text][Citation analysis]
article75
2002Recognising diversity in public preferences: the use of preference sub‐groups in cost‐effectiveness analysis. Authors reply In: Health Economics.
[Full Text][Citation analysis]
article0
2005Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra In: Health Economics.
[Full Text][Citation analysis]
article59
2005Assessing generalisability by location in trial‐based cost‐effectiveness analysis: the use of multilevel models In: Health Economics.
[Full Text][Citation analysis]
article19
2005Estimating mean QALYs in trial‐based cost‐effectiveness analysis: the importance of controlling for baseline utility In: Health Economics.
[Full Text][Citation analysis]
article31
2006Discounting and cost‐effectiveness in NICE – stepping back to sort out a confusion In: Health Economics.
[Full Text][Citation analysis]
article17
2006Evidence synthesis, parameter correlation and probabilistic sensitivity analysis In: Health Economics.
[Full Text][Citation analysis]
article8
2006Whither trial‐based economic evaluation for health care decision making? In: Health Economics.
[Full Text][Citation analysis]
article36
2010Sins of omission and obfuscation: IQWIGs guidelines on economic evaluation methods In: Health Economics.
[Full Text][Citation analysis]
article2
2011Dangerous omissions: the consequences of ignoring decision uncertainty In: Health Economics.
[Full Text][Citation analysis]
article11
2015CAUSES FOR CONCERN: IS NICE FAILING TO UPHOLD ITS RESPONSIBILITIES TO ALL NHS PATIENTS? In: Health Economics.
[Full Text][Citation analysis]
article15
2018Social value and individual choice: The value of a choice‐based decision‐making process in a collectively funded health system In: Health Economics.
[Full Text][Citation analysis]
article0
2018How to design the cost‐effectiveness appraisal process of new healthcare technologies to maximise population health: A conceptual framework In: Health Economics.
[Full Text][Citation analysis]
article1
1995Sensitivity analysis in economic evaluation: A review of published studies In: Health Economics.
[Full Text][Citation analysis]
article10
1998The cost‐effectiveness of preference‐based treatment allocation: the case of hysterectomy versus endometrial resection in the treatment of menorrhagia In: Health Economics.
[Full Text][Citation analysis]
article1
1995Economic Evaluation in Health Care Research and Development: Undertake it Early and Often In: Discussion Papers.
[Full Text][Citation analysis]
paper0
1996Antenatal testing for HIV Infection: Developing a Model for Economic Evaluation In: Discussion Papers.
[Full Text][Citation analysis]
paper0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated March, 2 2021. Contact: CitEc Team